StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PLUR

Pluri Inc.

PLUR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$1.58
+0.01 +0.96%

Key statistics

from XBRL data in SEC filings
Market cap
$17.0M
Revenue (TTM)
$1.08M
Net income (TTM)
$20.3M
EPS (TTM)
$-2.92
P/E ratio
Dividend yield
Free cash flow
-$19.8M
Cash
$3.42M
Total assets
$26.1M
Gross margin
43.0%
52-week range
$1.45 – $5.68

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 14, 2026 8-K Delisting notice or listing-rule failure Jul 13, 2026 8-K Entered a material agreement; Director or officer change; Shareholder vote results Jun 22, 2026 8-K Other events Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity Mar 27, 2026 8-K Other events Mar 2, 2026 10-Q Quarter ended 2025-12-31 Feb 12, 2026 8-K Delisting notice or listing-rule failure Jan 22, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Director or officer change Oct 16, 2025 10-K Fiscal year ended 2025-06-30 Sep 17, 2025 8-K Other events Sep 12, 2025 8-K Director or officer change Sep 11, 2025 8-K Delisting notice or listing-rule failure; Director or officer change; Shareholder vote results Jul 3, 2025 8-K Other events May 27, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Other events May 8, 2025 8-K Item 5.08 Apr 29, 2025 8-K Other events Apr 28, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 25, 2025 8-K Other events Apr 17, 2025 8-K Item 5.08 Mar 19, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 13, 2025 10-Q Quarter ended 2024-12-31 Feb 11, 2025 8-K Entered a material agreement; Unregistered sale of equity Feb 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Jan 29, 2025 8-K Delisting notice or listing-rule failure Jan 21, 2025 8-K Delisting notice or listing-rule failure Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Other events Oct 1, 2024 10-K Fiscal year ended 2024-06-30 Sep 18, 2024 8-K Delisting notice or listing-rule failure Jul 23, 2024 8-K Other events Jul 8, 2024 8-K Director or officer change Jul 2, 2024 8-K Shareholder vote results Jun 26, 2024 8-K Entered a material agreement Jun 18, 2024 8-K Delisting notice or listing-rule failure May 31, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024